Medical Marketing and Media - Pfizer's Neurontin ad is misleading: DDMAC
Friday, December 5th, 2008WASHINGTON INSIDER
Most Popular
3 Questions No Job Seeker Ever Wants To Be Asked?
Public Speaking: 7 Secrets Of Great Public Speakers
13 Job Interview Mistakes To Avoid
5 Regular Mistakes In Public Speaking
10 Jobs That Pay $30 An Hour
The Division of Drug Marketing, Advertising, and Communications (DDMAC) has ordered Pfizer Inc to discontinue use of Neurontin (gabapentin) promoti…
